摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

isobutyl N-(coumarin-3-yl)carbamate | 1442690-85-8

中文名称
——
中文别名
——
英文名称
isobutyl N-(coumarin-3-yl)carbamate
英文别名
isobutyl (coumarin-3-yl)carbamate;2-methylpropyl N-(2-oxochromen-3-yl)carbamate
isobutyl N-(coumarin-3-yl)carbamate化学式
CAS
1442690-85-8
化学式
C14H15NO4
mdl
——
分子量
261.277
InChiKey
WJDOZVLLYHCHJG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    64.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3-氨基香豆素氯甲酸异丁酯吡啶 作用下, 以 二氯甲烷 为溶剂, 以78%的产率得到isobutyl N-(coumarin-3-yl)carbamate
    参考文献:
    名称:
    Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives
    摘要:
    摘要 目的 为了找出影响对腺苷受体(ARs)结合活性和选择性的结构特征,合成了几种具有酰胺(化合物3-6)和碳酸酯(7-9)功能的3-取代香豆素。为了研究对结合活性和选择性的可能影响,在香豆素基团的4位还引入了一个羟基取代基。 方法 合成了一系列新的香豆素(3-9),并通过放射配体结合研究对ARs进行评估。 主要发现 4-羟基衍生物(4、8和9)中没有一个显示出对任何ARs的结合亲和力。没有任何化合物与hA2B AR相互作用(Ki > 100,000 nm)。化合物3、5、6和7具有不同的活性特征,对人类A1、A2A和A3 ARs的结合亲和力和选择性不同。 结论 最显著的衍生物是化合物7,它对A3腺苷受体具有最佳的亲和力和选择性(Ki = 5500 nm)。
    DOI:
    10.1111/j.2042-7158.2012.01571.x
点击查看最新优质反应信息

文献信息

  • Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives
    作者:Maria João Matos、Alexandra Gaspar、Sonja Kachler、Karl-Norbert Klotz、Fernanda Borges、Lourdes Santana、Eugenio Uriarte
    DOI:10.1111/j.2042-7158.2012.01571.x
    日期:2012.12.5
    Abstract Objectives

    With the aim of finding the structural features governing binding activity and selectivity against adenosine receptors (ARs), several 3-subtituted coumarins with amide (compounds 3–6) and carbamate (7–9) functions were synthesized. To study its possible influence on the binding activity and selectivity, a hydroxyl substituent was also introduced at position 4 of the coumarin moiety.

    Methods

    A new series of coumarins (3–9) were synthesized and evaluated by radioligand binding studies towards ARs.

    Key findings

    None of the 4-hydroxy derivatives (4, 8 and 9) showed binding affinity for any of the ARs. None of the compounds interacted with the hA2B AR (Ki > 100 000 nm). Compounds 3, 5, 6 and 7 had different activity profiles with dissimilar binding affinity and selectivity towards human A1, A2A and A3 ARs.

    Conclusions

    The most remarkable derivative is compound 7, which presents the best affinity and selectivity for the A3 adenosine receptor (Ki = 5500 nm).

    摘要 目的 为了找出影响对腺苷受体(ARs)结合活性和选择性的结构特征,合成了几种具有酰胺(化合物3-6)和碳酸酯(7-9)功能的3-取代香豆素。为了研究对结合活性和选择性的可能影响,在香豆素基团的4位还引入了一个羟基取代基。 方法 合成了一系列新的香豆素(3-9),并通过放射配体结合研究对ARs进行评估。 主要发现 4-羟基衍生物(4、8和9)中没有一个显示出对任何ARs的结合亲和力。没有任何化合物与hA2B AR相互作用(Ki > 100,000 nm)。化合物3、5、6和7具有不同的活性特征,对人类A1、A2A和A3 ARs的结合亲和力和选择性不同。 结论 最显著的衍生物是化合物7,它对A3腺苷受体具有最佳的亲和力和选择性(Ki = 5500 nm)。
  • Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study
    作者:Maria J. Matos、Santiago Vilar、Rosa Mª Gonzalez-Franco、Eugenio Uriarte、Lourdes Santana、Carol Friedman、Nicholas P. Tatonetti、Dolores Viña、Jose A. Fontenla
    DOI:10.1016/j.ejmech.2013.02.009
    日期:2013.5
    A series of (coumarin-3-yl)carbamates was synthesized and evaluated in vitro as monoamine oxidase (MAO-A and MAO-B) inhibitors. Most of the new compounds selectively inhibited MAO-B isoenzyme with IC50 values in the micro or nanoMolar ranges. Since these compounds must achieve the brain cells, theoretical evaluation of ADME properties were also carried out. Compound 8 (benzyl(coumarin-3yl)carbamate), which presented the most interesting in vitro MAO-B inhibitory profile (IC50 against MAO-B = 45 nM), was subjected to further studies. This in vitro MAO-B inhibitory activity is comparable with that of the selegiline, the reference compound (IC50 against MAO-B = 20 nM). Taking into account the in vitro results of compound 8, in vivo assays and docking calculations were also carried out for this derivative. (C) 2013 Elsevier Masson SAS. All rights reserved.
查看更多